263 related articles for article (PubMed ID: 29720252)
1. Estrogen induces St6gal1 expression and increases IgG sialylation in mice and patients with rheumatoid arthritis: a potential explanation for the increased risk of rheumatoid arthritis in postmenopausal women.
Engdahl C; Bondt A; Harre U; Raufer J; Pfeifle R; Camponeschi A; Wuhrer M; Seeling M; Mårtensson IL; Nimmerjahn F; Krönke G; Scherer HU; Forsblad-d'Elia H; Schett G
Arthritis Res Ther; 2018 May; 20(1):84. PubMed ID: 29720252
[TBL] [Abstract][Full Text] [Related]
2. B-cell-independent sialylation of IgG.
Jones MB; Oswald DM; Joshi S; Whiteheart SW; Orlando R; Cobb BA
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):7207-12. PubMed ID: 27303031
[TBL] [Abstract][Full Text] [Related]
3. IgG sialylation occurs in B cells pre antibody secretion.
Werner A; Hanić M; Zaitseva OO; Lauc G; Lux A; Nitschke L; Nimmerjahn F
Front Immunol; 2024; 15():1402000. PubMed ID: 38827747
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory IgG production requires functional P1 promoter in β-galactoside α2,6-sialyltransferase 1 (ST6Gal-1) gene.
Jones MB; Nasirikenari M; Lugade AA; Thanavala Y; Lau JT
J Biol Chem; 2012 May; 287(19):15365-70. PubMed ID: 22427662
[TBL] [Abstract][Full Text] [Related]
5. Bazedoxifene does not share estrogens effects on IgG sialylation.
Gupta P; Horkeby K; Carlsten H; Henning P; Engdahl C
PLoS One; 2023; 18(5):e0285755. PubMed ID: 37200319
[TBL] [Abstract][Full Text] [Related]
6. Platelet-localized ST6Gal1 does not impact IgG sialylation.
Glendenning LM; Zhou JY; Kukan EN; Gao C; Cummings RD; Joshi S; Whiteheart SW; Cobb BA
Glycobiology; 2023 Dec; 33(11):943-953. PubMed ID: 37379323
[TBL] [Abstract][Full Text] [Related]
7. ST6Gal1 in plasma is dispensable for IgG sialylation.
Oswald DM; Lehoux SD; Zhou JY; Glendenning LM; Cummings RD; Cobb BA
Glycobiology; 2022 Aug; 32(9):803-813. PubMed ID: 35746897
[TBL] [Abstract][Full Text] [Related]
8. CCCTC-binding factor: the specific transcription factor of β-galactoside α-2,6-sialyltransferase 1 that upregulates the sialylation of anti-citrullinated protein antibodies in rheumatoid arthritis.
Zhao H; Wang H; Qin Y; Ling S; Zhai H; Jin J; Fang L; Cao Z; Jin S; Yang X; Wang J
Rheumatology (Oxford); 2024 Mar; 63(3):826-836. PubMed ID: 37326830
[TBL] [Abstract][Full Text] [Related]
9. Divergent Golgi trafficking limits B cell-mediated IgG sialylation.
Glendenning LM; Zhou JY; Reynero KM; Cobb BA
J Leukoc Biol; 2022 Dec; 112(6):1555-1566. PubMed ID: 35726710
[TBL] [Abstract][Full Text] [Related]
10. Blood-Borne ST6GAL1 Regulates Immunoglobulin Production in B Cells.
Irons EE; Punch PR; Lau JTY
Front Immunol; 2020; 11():617. PubMed ID: 32391003
[TBL] [Abstract][Full Text] [Related]
11. Impact of estrogen on IgG glycosylation and serum protein glycosylation in a murine model of healthy postmenopause.
Gupta P; Sághy T; Nordqvist J; Nilsson J; Carlsten H; Horkeby K; Henning P; Engdahl C
Front Endocrinol (Lausanne); 2023; 14():1243942. PubMed ID: 37766692
[TBL] [Abstract][Full Text] [Related]
12. Loss of α2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritis.
Wang Y; Khan A; Antonopoulos A; Bouché L; Buckley CD; Filer A; Raza K; Li KP; Tolusso B; Gremese E; Kurowska-Stolarska M; Alivernini S; Dell A; Haslam SM; Pineda MA
Nat Commun; 2021 Apr; 12(1):2343. PubMed ID: 33879788
[TBL] [Abstract][Full Text] [Related]
13. Branch-specific sialylation of IgG-Fc glycans by ST6Gal-I.
Barb AW; Brady EK; Prestegard JH
Biochemistry; 2009 Oct; 48(41):9705-7. PubMed ID: 19772356
[TBL] [Abstract][Full Text] [Related]
14. Loss of core fucosylation in both ST6GAL1 and its substrate enhances glycoprotein sialylation in mice.
Huang G; Li Z; Li Y; Liu G; Sun S; Gu J; Kameyama A; Li W; Dong W
Biochem J; 2020 Mar; 477(6):1179-1201. PubMed ID: 32141499
[TBL] [Abstract][Full Text] [Related]
15. Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs.
Oefner CM; Winkler A; Hess C; Lorenz AK; Holecska V; Huxdorf M; Schommartz T; Petzold D; Bitterling J; Schoen AL; Stoehr AD; Vu Van D; Darcan-Nikolaisen Y; Blanchard V; Schmudde I; Laumonnier Y; Ströver HA; Hegazy AN; Eiglmeier S; Schoen CT; Mertes MM; Loddenkemper C; Löhning M; König P; Petersen A; Luger EO; Collin M; Köhl J; Hutloff A; Hamelmann E; Berger M; Wardemann H; Ehlers M
J Allergy Clin Immunol; 2012 Jun; 129(6):1647-55.e13. PubMed ID: 22502800
[TBL] [Abstract][Full Text] [Related]
16. Engineering a bacterial sialyltransferase for di-sialylation of a therapeutic antibody.
Wang M; Wang Y; Liu K; Dou X; Liu Z; Zhang L; Ye XS
Org Biomol Chem; 2020 Apr; 18(15):2886-2892. PubMed ID: 32236230
[TBL] [Abstract][Full Text] [Related]
17. Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis.
Ohmi Y; Ise W; Harazono A; Takakura D; Fukuyama H; Baba Y; Narazaki M; Shoda H; Takahashi N; Ohkawa Y; Ji S; Sugiyama F; Fujio K; Kumanogoh A; Yamamoto K; Kawasaki N; Kurosaki T; Takahashi Y; Furukawa K
Nat Commun; 2016 Apr; 7():11205. PubMed ID: 27046227
[TBL] [Abstract][Full Text] [Related]
18. IgG and leukocytes: Targets of immunomodulatory α2,6 sialic acids.
Jones MB
Cell Immunol; 2018 Nov; 333():58-64. PubMed ID: 29685495
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.
Kaneko Y; Nimmerjahn F; Ravetch JV
Science; 2006 Aug; 313(5787):670-3. PubMed ID: 16888140
[TBL] [Abstract][Full Text] [Related]
20. Suppression of Experimental Arthritis and Associated Bone Loss by a Tissue-Selective Estrogen Complex.
Andersson A; Bernardi AI; Nurkkala-Karlsson M; Stubelius A; Grahnemo L; Ohlsson C; Carlsten H; Islander U
Endocrinology; 2016 Mar; 157(3):1013-20. PubMed ID: 26745543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
